Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023).
| dc.contributor.author | Muñoz Báez, Paloma | |
| dc.contributor.author | Illescas López, Marta | |
| dc.contributor.author | Salazar, Adolfo de | |
| dc.contributor.author | Falces Romero, Iker | |
| dc.contributor.author | Pinto, Adriana | |
| dc.contributor.author | Portilla, Irene | |
| dc.contributor.author | Masiá, Mar | |
| dc.contributor.author | Peraire, Joaquim | |
| dc.contributor.author | Alemán Valls, María Remedios | |
| dc.contributor.author | Suárez García, Inés | |
| dc.contributor.author | Et. al. | |
| dc.date.accessioned | 2026-08-27T10:07:18Z | |
| dc.date.available | 2026-08-27T10:07:18Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | While surveillance drug resistance mutations remain essential for monitoring transmitted drug resistance, the clinical impact of transmitted resistance for current first-line regimens has become increasingly important. This study aimes to update estimates of TDR in Spain and assess its clinical impact over time. | en |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 3.8 Q2 JCR 2025 | |
| dc.description.impact | 1.428 Q1 SJR 2025 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | Instituto de Salud Carlos III (PI22/00882) | es |
| dc.description.sponsorship | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CB21/13/00091) | es |
| dc.identifier.citation | Muñoz Báez, P., Illescas López, M., De Salazar, A., Falces Romero, I., Pinto, A., Portilla, I., Masiá, M., Peraire, J., Alemán Valls, M. R., Sanchiz, M., Iborra, A., Baza, B., Aguilera, A., Olalla, J., Espinosa, N., Iribarren, J. A., Gisbert, L., Imaz, A., Montero, M., … García, F. (2026). Beyond surveillance mutations: Long-term trends and clinical relevance of transmitted hiv drug resistance in spain(2007–2023). Open Forum Infectious Diseases, 13(6), ofag296. https://doi.org/10.1093/ofid/ofag296 | |
| dc.identifier.doi | 10.1093/ofid/ofag296 | |
| dc.identifier.issn | 2328-8957 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17383 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1093/ofid/ofag296 | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.other | Departamento clínico | |
| dc.subject.other | VIH | |
| dc.subject.other | Profilaxis pre-exposición | |
| dc.subject.other | Integrasas | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Sida | |
| dc.subject.unesco | Medicina preventiva | |
| dc.subject.unesco | Investigación médica | |
| dc.title | Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023). | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | c319367b-46e4-44b2-98ea-a3b303e36262 | |
| relation.isAuthorOfPublication | c319367b-46e4-44b2-98ea-a3b303e36262 | |
| relation.isAuthorOfPublication.latestForDiscovery | c319367b-46e4-44b2-98ea-a3b303e36262 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Beyond surveillance mutations
- Size:
- 566.09 KB
- Format:
- Adobe Portable Document Format

